PET staging of amyloidosis using striatum
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Introduction: Amyloid positron emission tomography (PET) data are commonly expressed as binary measures of cortical deposition. However, not all individuals with high cortical amyloid will experience rapid cognitive decline. Motivated by postmortem data, we evaluated a three‐stage PET classification: low cortical; high cortical, low striatal; and high cortical, high striatal amyloid; hypothesizing this model could better reflect Alzheimer's dementia progression than a model based only on cortical measures. Methods: We classified PET data from 1433 participants (646 normal, 574 mild cognitive impairment, and 213 AD), explored the successive involvement of cortex and striatum using 3‐year follow‐up PET data, and evaluated the associations between PET stages, hippocampal volumes, and cognition. Results: Follow‐up data indicated that PET detects amyloid first in cortex and then in striatum. Our three‐category staging including striatum better predicted hippocampal volumes and subsequent cognition than a three‐category staging including only cortical amyloid. Discussion: PET can evaluate amyloid expansion from cortex to subcortex. Using striatal signal as a marker of advanced amyloidosis may increase predictive power in Alzheimer's dementia research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 2×
“We evaluated the predictive value of a PET measure from striatum, a subcortical structure in which Ab is typically detected at autopsy only after cortical deposition [10] and in which corresponding PET measures are readily available [3].”
MethodResultMontine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Nakamura, A., Kaneko, N., Villemagne, V. L., Kato, T., Doecke, J., Doré, V., Fowler, C., Li, Q.-X., Martins, R., Rowe, C., et al. (2018) · Nature · doi:10.1038/nature25456 · Cited by 1,681
PET Imaging of Tau Deposition in the Aging Human Brain
Schöll, M., Lockhart, S. N., Schonhaut, D. R., O’Neil, J. P., Janabi, M., Ossenkoppele, R., Baker, S. L., Vogel, J. W., Faria, J., Schwimmer, H. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.028 · Cited by 1,214
Tau positron emission tomographic imaging in aging and early Alzheimer disease
Johnson, K. A., Schultz, A., Betensky, R. A., Becker, J. A., Sepulcre, J., Rentz, D., Mormino, E., Chhatwal, J., Amariglio, R., Papp, K., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24546 · Cited by 986
Self-citationClark, C. M., Pontecorvo, M. J., Beach, T. G., Bedell, B. J., Coleman, R. E., Doraiswamy, P. M., Fleisher, A. S., Reiman, E. M., Sabbagh, M. N., Sadowsky, C. H., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70142-4 · Cited by 855
Morris, J. C., Roe, C. M., Grant, E. A., Head, D., Storandt, M., Goate, A. M., Fagan, A. M., Holtzman, D. M., & Mintun, M. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.269 · Cited by 476
Donohue, M. C., Sperling, R. A., Petersen, R., Sun, C.-K., Weiner, M. W., Aisen, P. S., & Initiative, F. T. A. D. N. (2017) · JAMA · doi:10.1001/jama.2017.6669 · Cited by 452
Self-citationIn vivo staging of regional amyloid deposition
Grothe, M. J., Barthel, H., Sepulcre, J., Dyrba, M., Sabri, O., Teipel, S. J., Initiative, F. T. A. D. N., Initiative, A. D. N., Weiner, M., Aisen, P., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004643 · Cited by 440 · cited 1×
“Consistent with the view that FBP is able to detect striatal Ab, a recent ADNI study showed that striatal FBP signal correlated with Ab CSF measures [29].”
ResultSelf-citationSchwarz, A. J., Yu, P., Miller, B. B., Shcherbinin, S., Dickson, J., Navitsky, M., Joshi, A. D., Devous, M. D., & Mintun, M. S. (2016) · Brain · doi:10.1093/brain/aww023 · Cited by 425
Research works printed but not linked: 20
- 10.1186/s40478-016-0399-z · DOI · Paper page
- 10.3233/JAD-150732 · DOI
- 10.1212/WNL.0000000000001209 · DOI · Paper page
- 10.1212/WNL.0b013e3182563bbe · DOI · Paper page
- 10.1016/j.jalz.2013.11.005 · DOI · Paper page
- 10.1016/j.neurobiolaging.2016.08.017 · DOI
- 10.1016/S1474-4422(13)70044-9 · DOI · Paper page
- 10.1016/j.jalz.2017.01.018 · DOI · Paper page
- 10.1007/s11682-012-9186-z · DOI · Paper page
- 10.1007/s11682-012-9176-1 · DOI · Paper page
- 10.2967/jnumed.114.148981 · DOI · Paper page
- 10.2967/jnumed.112.109009 · DOI · Paper page
- Ard M.C., 2011, Power calculations for clinical trials in Alzheimer's disease, J Alzheimers Dis, 26, 369, 10.3233/JAD-2011-0062 · DOI · Paper page
- 10.1016/S1474-4422(15)00323-3 · DOI · Paper page
- 10.1126/scitranslmed.3007941 · DOI · Paper page
- 10.1001/archneurol.2009.285 · DOI · Paper page
- 10.1016/j.jalz.2011.09.229 · DOI · Paper page
- 10.1212/WNL.0000000000000431 · DOI · Paper page
- Dugger B.N., 2012, Presence of striatal amyloid plaques in Parkinson's Disease dementia predicts concomitant Alzheimer's disease: usefulness for amyloid imaging, J Parkinsons Dis, 2, 57, 10.3233/JPD-2012-11073 · DOI · Paper page
- 10.1212/WNL.0000000000000721 · DOI · Paper page
Cited by
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
Frisoni, G. B., Altomare, D., Thal, D. R., Ribaldi, F., van der Kant, R., Ossenkoppele, R., Blennow, K., Cummings, J., van Duijn, C., Nilsson, P. M., et al. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00533-w · Cited by 513
Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum
Moscoso, A., Grothe, M. J., Ashton, N. J., Karikari, T. K., Rodriguez, J. L., Snellman, A., Suárez-Calvet, M., Zetterberg, H., Blennow, K., Schöll, M., et al. (2021) · Brain · doi:10.1093/brain/awaa399 · Cited by 229
Sanchez, J. S., Becker, J. A., Jacobs, H. I. L., Hanseeuw, B. J., Jiang, S., Schultz, A. P., Properzi, M. J., Katz, S. R., Beiser, A., Satizabal, C. L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc0655 · Cited by 200
“Global A burden was represented using PiB DVR in a large neocortical aggregate (FS-defined FLR region) (12, 60).”
MethodSelf-citationSepulveda-Falla, D., Sanchez, J. S., Almeida, M. C., Boassa, D., Acosta-Uribe, J., Vila-Castelar, C., Ramirez-Gomez, L., Baena, A., Aguillon, D., Villalba-Moreno, N. D., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02467-8 · Cited by 92
Self-citationEarly detection of amyloid load using 18F-florbetaben PET
Bullich, S., Roé-Vellvé, N., Marquié, M., Landau, S. M., Barthel, H., Villemagne, V. L., Sanabria, Á., Tartari, J. P., Sotolongo-Grau, O., Doré, V., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00807-6 · Cited by 71
Metadata
- Authors
- Hanseeuw, B. J., Betensky, R. A., Mormino, E. C., Schultz, A. P., Sepulcre, J., Becker, J. A., Jacobs, H. I. L., Buckley, R. F., LaPoint, M. R., Vannini, P., Donovan, N. J., Chhatwal, J. P., Marshall, G. A., Papp, K. V., Amariglio, R. E., Rentz, D. M., Sperling, R. A., Johnson, K. A., Initiative, F. T. A. D. N., & Study, A. T. H. A. B.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2018-05-21
- Volume
- 14
- Issue
- 10
- Pages
- 1281-1292
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2803295480
- Cited by
- 130
- References
- 16
- FWCI
- 10.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- Alzheimer's Association
- Harvard NeuroDiscovery Center
- Fidelity Biosciences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PET staging of amyloidosis using striatum. https://app.cochat.ai/papers/10.1016/j.jalz.2018.04.011
- The paper
- Hanseeuw, B. J., Betensky, R. A., Mormino, E. C., Schultz, A. P., Sepulcre, J., Becker, J. A., Jacobs, H. I. L., Buckley, R. F., LaPoint, M. R., Vannini, P., Donovan, N. J., Chhatwal, J. P., Marshall, G. A., Papp, K. V., Amariglio, R. E., Rentz, D. M., Sperling, R. A., Johnson, K. A., Initiative, F. T. A. D. N., & Study, A. T. H. A. B. (2018). PET staging of amyloidosis using striatum. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2018.04.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.